Auditory Stimulation for Rolandic Epilepsy
Trial Summary
What is the purpose of this trial?
The investigators are recruiting children with Rolandic epilepsy and children without epilepsy (aged 4 years old and above) for a non-invasive brain imaging study using Magnetic Resonance Imaging (MRI), Magnetoencephalography/Electroencephalography (MEG/EEG), and experimental tasks. The investigators hope to determine the brain circuits and brain rhythms affected in these children and ultimately identify new treatment options for childhood epilepsy patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Auditory stimulation for Rolandic Epilepsy?
Research shows that auditory stimulation can reduce seizure duration and frequency in individuals with epilepsy, as seen in a study where a patient's seizures decreased from 5.70 to 2.66 per day. Additionally, specific auditory stimuli have been found to evoke anti-seizure brain activity in patients with neurological conditions.12345
Is auditory stimulation safe for humans?
How does auditory stimulation treatment differ from other treatments for rolandic epilepsy?
Auditory stimulation for rolandic epilepsy is unique because it uses specific sounds or music to activate the brain and reduce seizures, unlike traditional treatments that often involve medication. This approach is non-invasive and leverages the brain's response to sound to help control seizure activity.12378
Research Team
Catherine J Chu, MD
Principal Investigator
Massachusetts General Hospital
Eligibility Criteria
This trial is for children aged 4-18 with Rolandic epilepsy, who've had at least one seizure and show specific brain activity patterns on an EEG. It's not for those with abnormal MRIs, other neurological diseases, metal implants or braces, claustrophobia, a history of frequent vomiting, or over the MRI weight limit.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Experimental Task and Imaging
Participants undergo MRI, MEG/EEG, and training on a memory task with auditory stimulation during a nap
Follow-up
Participants are monitored for safety and effectiveness after the experimental tasks
Treatment Details
Interventions
- Auditory stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Boston University
Collaborator